FEDERICO
GARRIDO TORRES-PUCHOL
Investigador desde 2023
MIGUEL ÁNGEL
LÓPEZ NEVOT
PROFESOR TITULAR DE UNIVERSIDAD
Publicaciones en las que colabora con MIGUEL ÁNGEL LÓPEZ NEVOT (41)
2022
-
Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients
Journal of Microbiology, Immunology and Infection, Vol. 55, Núm. 3, pp. 421-427
2011
-
Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors
Immunogenetics, Vol. 63, Núm. 2, pp. 65-71
2007
-
Analysis of HLA class I alterations in tumors: Choosing a strategy based on known patterns of underlying molecular mechanisms
Tissue Antigens
-
Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours
Tissue Antigens, Vol. 69, Núm. 3, pp. 220-226
-
MHC Class I Antigens and Immune Surveillance in Transformed Cells
International Review of Cytology, Vol. 256, pp. 139-189
-
Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response
International Journal of Cancer, Vol. 121, Núm. 9, pp. 2023-2030
2006
-
LOH at 6p21.3 region and HLA class altered phenotypes in bladder carcinomas
Immunogenetics, Vol. 58, Núm. 7, pp. 503-510
2005
-
High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity
Cancer Immunology, Immunotherapy, Vol. 54, Núm. 2, pp. 141-148
-
Involvement of the chaperone tapasin in HLA-B44 allelic losses in colorectal tumors
International Journal of Cancer, Vol. 113, Núm. 4, pp. 611-618
-
TAP1 and TAP2 polymorphisms and their linkage disequilibrium with HLA-DR, -DP, and -DQ in an Eastern Andalusian population
Human Immunology, Vol. 66, Núm. 8, pp. 921-930
2004
-
Distribution of HLA class I altered phenotypes in colorectal carcinomas: High frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21
Immunogenetics, Vol. 56, Núm. 4, pp. 244-253
2003
-
Analysis of HLA expression in human tumor tissues
Cancer Immunology, Immunotherapy, Vol. 52, Núm. 1, pp. 1-9
-
High frequency of HLA-B44 allelic losses in human solid tumors
Human Immunology, Vol. 64, Núm. 10, pp. 941-950
2002
-
Impaired surface antigen presentation in tumors: Implications for T cell-based immunotherapy
Seminars in Cancer Biology, Vol. 12, Núm. 1, pp. 15-24
-
Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: High frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21
Cancer Immunology, Immunotherapy, Vol. 51, Núm. 7, pp. 389-396
2001
-
A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-a*0301 allele in a prostate carcinoma cell line
Immunogenetics, Vol. 53, Núm. 7, pp. 606-610
-
HLA class II allele distribution in the Gypsy community of Andalusia, southern Spain
Tissue Antigens, Vol. 57, Núm. 2, pp. 138-143
-
Loss of HLA-B44 and type II altered HLA phenotype in human tumors
European Journal of Immunogenetics, Vol. 28, Núm. 2, pp. 327
2000
-
Criteria to define HLA haplotype loss in human solid tumors
Tissue Antigens
-
Molecular strategies to define HLA haplotype loss in microdissected tumor cells
Human Immunology, Vol. 61, Núm. 10, pp. 1001-1012